Association study between autistic-like traits and polymorphisms in the autism candidate regions RELN, CNTNAP2, SHANK3, and CDH9/10 by Jonsson, Lina et al.
Jonsson et al. Molecular Autism 2014, 5:55
http://www.molecularautism.com/content/5/1/55SHORT REPORT Open AccessAssociation study between autistic-like traits and
polymorphisms in the autism candidate regions
RELN, CNTNAP2, SHANK3, and CDH9/10
Lina Jonsson1*, Anna Zettergren1, Erik Pettersson2, Daniel Hovey1, Henrik Anckarsäter3, Lars Westberg1,
Paul Lichtenstein2, Sebastian Lundström3,4,5 and Jonas Melke1Abstract
Background: Autistic-like traits (ALTs) are continuously distributed in the general population, with the autism
spectrum disorder (ASD) at the upper extreme end. A genetic overlap has been shown between ALTs and ASD,
indicating that common variation in ASD candidate genes may also influence ALTs. In our study, we have
investigated the SNP rs4307059 that has been associated with both ALTs and ASD. In addition, we genotyped
polymorphisms in a selection of genes involved in synaptic functioning, that is, SHANK3, RELN, and CNTNAP2, which
repeatedly have been associated with ASD. The possible associations of these polymorphisms with ALTs, as well as
genetic factors for neurodevelopmental problems (NDPs), were investigated in a large cohort from the general
population: The Child and Adolescent Twin Study in Sweden. For analyses of ALTs and NDPs, 12,319 subjects
(including 2,268 monozygotic (MZ) and 3,805 dizygotic (DZ) twin pairs) and 8,671 subjects (including 2,243 MZ
and 2,044 DZ twin pairs), respectively, were included in the analyses.
Findings: We could not replicate the previous association between rs4307059 and social communication
impairment. Moreover, common variations in CNTNAP2 (rs7794745 and rs2710102), RELN (rs362691), and SHANK3
(rs9616915) were not significantly associated with ALTs in our study.
Conclusions: Our results do not suggest that the investigated genes, which previously has been found associated
with ASD diagnosis, have any major influence on ALTs in children from the general population.
Keywords: Autistic-like traits, Autism spectrum disorder, CNTNAP2, RELN, rs4307059, SHANK3, A-TAC, CATSSFindings
Background
Autism spectrum disorder (ASD) is a heterogeneous
group of neurodevelopmental disorders that are charac-
terized by impairments in social interaction restricted
and repetitive behavior and communication impair-
ments. Furthermore, there is a large co-morbidity be-
tween ASD and other neurodevelopmental disorders,
such as Attention Deficit/Hyperactive Disorder (ADHD)
[1] and a shared genetic susceptibility has been sug-
gested for neurodevelopmental disorders [2].* Correspondence: lina.jonsson@neuro.gu.se
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unless otherwise stated.The phenotypic heterogeneity within ASD is probably
the major explanation for the inconclusive results from
genetic studies of ASD. Indeed, the majority of genes
and biological pathways clearly implicated in ASD
have been identified in studies of rare variation [3],
whereas studies of common polymorphisms, both in
large, genome-wide association studies (GWAS) [4-6]
and smaller hypothesis driven studies have yielded in-
conclusive results [3]. Another approach to investigate
the role of common variants in ASD is to assess
milder, non-pathological phenotypes related to ASD,
such as autistic-like traits (ALTs), that are dimension-
ally distributed in the general population [7]. Theoret-
ically, common variations would have a larger impactl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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also allows for analyses of the genetics for different as-
pects of the autistic phenotype separately [8]. Indeed,
it has been shown that ALTs and clinical ASD are etio-
logically related [7] and one example of a single nu-
cleotide polymorphism (SNP) that has been associated
both with ASD [5] and social interaction impairment
is a SNP (rs4307059) between the genes Cadherin 9 and 10
(CDH9 and CDH10) [9]. Also, a SNP (rs2710102) in the
Contactin associated protein-like 2 (CNTNAP2) has been
shown to affect language development in the general popu-
lation [10] and age at first word in children with ASD [11].
Genetically determined abnormalities in neurodevelop-
ment and synaptic functioning are increasingly recog-
nized as a cause of ASD. Although these findings
primarily are based on rare mutations identified in ASD
families [12-14], there is evidence for an influence of
also common polymorphisms in ASD [3]. In the present
study we initially evaluated the association between
common variation in three genes involved in neurodeve-
lopment and/or synaptic function, that is, CNTNAP2,
SH3, and multiple ankyrin repeat domains 3 (SHANK3)
and Reelin (RELN), and continuous measures of ALTs.
Second, we investigated the possible influence of rs4307059
(between CDH9 and CDH10) and rs2710102 (CNTNAP2)
on both ALTs and ASD. Finally, we explored the influence
of the five SNPs on neurodevelopmental problems (NDPs).
Thus, the purpose of our study was to expand and partly
replicate previous findings regarding these SNPs in autism
related phenotypes.
Subjects and methods
Participants and measurements
The subjects in our study are part of The Child and
Adolescent Twin Study in Sweden (CATSS) that is fo-
cusing on neurodevelopmental problems in children
[15]. Our sample from the CATSS included 2,301 mono-
zygotic (MZ) twin pairs, 3,870 dizygotic (DZ) twin pairs,
and 84 subjects included without their co-twin. From
this sample, we have excluded 107 subjects due to docu-
mented brain damage or a known genetic syndrome; a
total of 12,319 subjects were included in our analyses of
ALTs. For analysis of NDPs a total of 8,671 subjects were
included: 2,243 MZ and 2,044 DZ twin pairs, and 97
subjects without their co-twin. The CATSS study has
ethical approval from the Karolinska Institutet Ethical
Review Board, and informed consent was obtained from
the participants.
The parental questionnaire Autism-Tics, ADHD, and
other Co-morbidities inventory (A-TAC) was answered
by the parents in connection to their twins’ 9th or 12th
birthday [16,17]; 70% are 9 years old (N = 8,623) and
30% are 12 years old (N = 3,696) at the time of testing.
The A-TAC consists of 96 questions, of which 17 measureALTs: six questions correspond to the language impair-
ment, six to the social interaction impairment, and five to
restricted and repetitive behavior. The A-TAC score can
also be used as a proxy for a clinical ASD diagnosis if the
children score higher than 8.5 points on the scale (N = 90
in our sample) [17]. Furthermore, 53 items in the A-TAC
have been used to identify a general genetic factor, that is,
a factor that consists of all neurodevelopmental problems
(NDPs) as well as three genetic subfactors (tics and
autism, hyperactivity, and learning problems) that were
independent of the general genetic factor and primarily
identified by a smaller number of specific symptoms [18].
These four factors were based on over 6,500 twin pairs
and were designed to have 100% heritability by fixing the
correlations across twin pairs at their expected genetic
pedigree (that is, at r = 1.0 for MZ and at r = 0.50 for DZ
twins). Since the calculations are based on a heritability es-
timate that is twice the difference between MZ and DZ
twins, the factors end up having 100% heritability. Please
note that the 100% heritability is a statistical routine to
maximize factor loading, rather than an actual estimate of
the heritability of these traits. By relying on the expected
twin correlations, factor analysis identified the specific set
of weights for the items that were perfectly heritable. Be-
cause one factor had substantial and positive weights on
all 53 items, it was considered general, that is, all symp-
toms partly shared the same genetic origin. Given that
these factors were entirely genetic in origin, their associa-
tions with specific candidate genes may emerge more
clearly.
Genotyping and statistical analyses
Five single nucleotide polymorphisms (SNPs) in the
genes CNTNAP2 (rs2710102 and rs7794745), RELN
(rs362691), SHANK3 (rs9616915), and rs4307059 be-
tween CDH9 and CDH10 were genotyped. DNA was ex-
tracted from saliva using OraGene DNA Self-collection
Kit (DNA Genotek Inc., Ottawa, Canada) and the SNPs
were genotyped using the Kompetitive Allele Specific PCR
(KASP) Genotyping System (LGC Genomics, Herts, UK).
All of the SNPs were in Hardy-Weinberg Equilibrium
(P >0.01) and the genotyping success rate was above 97%.
Statistical association, for ALTs and NDPs, were esti-
mated using linear mixed effect models in the MIXED
procedure (PROC MIXED) and for the case–control
analyses we used the GLIMMIX procedure of SAS 9.3
(SAS Institute, Inc., Cary, NC, USA). Both of these
models allowed us to adjust for the dependent nature of
the twin observations, that is, A-TAC scores from all ge-
notyped subjects were included in the analyses. For the
MIXED procedure, the genotypes were coded as quanti-
tative measures (0 =major allele homozygote, 1 = hetero-
zygote, and 2 =minor allele homozygote) and effect sizes
are presented as the regression coefficients for these
Table 1 Association between five SNPs and autistic-like traits
Autistic-like traitsa Autistic-like traits domains
Restricted & repetitive behaviora Social interaction impairmenta Language impairmenta
Gene/
SNP
MAF Genotype N All N Boys N Girls All Boys Girls All Boys Girls All Boys Girls
CDH9/10
rs4307059 0.37
(C)
C/C 1,663 0.68 (1.37) 796 0.86 (1.63) 867 0.50 (1.06) 0.23 (0.57) 0.31 (0.69) 0.16 (0.42) 0.23 (0.57) 0.29 (0.64) 0.18 (0.49) 0.21 (0.52) 0.27 (0.59) 0.16 (0.43)
T/C 5,564 0.73 (1.44) 2,820 0.91 (1.66) 2,744 0.54 (1.14) 0.23 (0.57) 0.30 (0.66) 0.16 (0.45) 0.25 (0.58) 0.30 (0.64) 0.21 (0.50) 0.24 (0.57) 0.30 (0.65) 0.18 (0.46)
T/T 4,766 0.67 (1.36) 2,391 0.85 (1.64) 2,375 0.50 (0.98) 0.21 (0.55) 0.28 (0.65) 0.14 (0.40) 0.24 (0.58) 0.29 (0.68) 0.19 (0.45) 0.22 (0.54) 0.27 (0.62) 0.17 (0.44)
P value 0.737 0.634 0.724 0.160 0.302 0.162 0.793 0.762 0.669 0.725 0.704 0.357
Effect size (CI 95%)c 0.007
(−0.033,
0.047)
0.016
(−0.051,
0.083)
0.007
(−0.033,
0.048)
0.011
(−0.004,
0.027)
0.014
(−0.013,
0.041)
0.011
(−0.005,
0.028)
−0.002
(−0.018,
0.014)
−0.004
(−0.03,
0.022)
0.004
(−0.014,
0.022)
0.003
(−0.019,
0.013)
0.005
(−0.020,
0.030)
−0.008
(−0.026,
0.009)
CNTNAP2
rs2710102 0.48
(G)
A/A 3,248 0.69 (1.37) 1,618 0.87 (1.63) 1,630 0.52 (1.03) 0.22 (0.57) 0.29 (0.68) 0.15 (0.43) 0.25 (0.57) 0.30 (0.65) 0.20 (0.48) 0.22 (0.53) 0.27 (0.61) 0.17 (0.42)
A/G 5,976 0.70 (1.41) 2,998 0.88 (1.68) 2,978 0.52 (1.04) 0.22 (0.56) 0.29 (0.66) 0.15 (0.42) 0.24 (0.58) 0.29 (0.66) 0.20 (0.47) 0.23 (0.57) 0.29 (0.65) 0.18 (0.46)
G/G 2,752 0.73 (1.45) 1,382 0.90 (1.60) 1,370 0.55 (1.24) 0.23 (0.58) 0.31 (0.65) 0.16 (0.47) 0.25 (0.58) 0.29 (0.64) 0.21 (0.51) 0.24 (0.56) 0.30 (0.62) 0.18 (0.49)
P value 0.523 0.652 0.727 0.593 0.566 0.880 0.827 0.653 0.766 0.336 0.368 0.542
Effect size (CI 95%)c 0.013
(−0.026,
0.052)
0.015
(−0.050,
0.080)
0.007
(−0.033,
0.048)
0.004
(−0.011,
0.020)
0.008
(−0.018,
0.033)
−0.001
(−0.017,
0.015)
−0.002
(−0.018,
0.014)
−0.006
(−0.031,
0.020)
0.003
(−0.015,
0.020)
0.008
(−0.008,
0.023)
0.011
(−0.013,
0.036)
0.006
(−0.012,
0.023)
rs7794745 0.36
(T)
A/A 5,004 0.72 (1.46) 2,475 0.92 (1.73) 2,529 0.53 (1.10) 0.24 (0.60) 0.32 (0.71) 0.16 (0.44) 0.25 (0.59) 0.30 (0.67) 0.19 (0.49) 0.24 (0.57) 0.29 (0.65) 0.19 (0.47)
T/A 5,533 0.70 (1.41) 2,807 0.87 (1.63) 2,726 0.53 (1.13) 0.22 (0.55) 0.28 (0.63) 0.15 (0.44) 0.26 (0.59) 0.30 (0.66) 0.21 (0.50) 0.23 (0.56) 0.29 (0.64) 0.17 (0.46)
T/T 1,564 0.67 (1.23) 779 0.82 (1.44) 785 0.51 (0.97) 0.22 (0.52) 0.29 (0.59) 0.15 (0.42) 0.22 (0.50) 0.25 (0.58) 0.20 (0.42) 0.22 (0.51) 0.28 (0.59) 0.16 (0.41)
P value 0.102 0.045b 0.744 0.126 0.081 0.847 0.309 0.050b 0.311 0.182 0.299 0.480
Effect size (CI 95%)c −0.034
(−0.075,
0.007)
−0.069
(−0.136,
−0.001)
0.007
(−0.035,
0.049)
−0.013
(−0.029,
0.004)
−0.024
(−0.051,
0.003)
−0.002
(−0.018,
0.015)
−0.009
(−0.025,
0.008)
−0.026
(−0.053,
<0.001)
0.009
(−0.009,
0.028)
−0.011
(−0.027,
0.005)
−0.014
(−0.039,
0.012)
−0.007
(−0.025,
0.012)
RELN
rs362691 0.13
(C)
C/C 211 0.65 (1.34) 107 0.66 (1.11) 104 0.63 (1.54) 0.22 (0.56) 0.25 (0.54) 0.18 (0.58) 0.25 (0.55) 0.24 (0.44) 0.25 (0.65) 0.18 (0.45) 0.17 (0.41) 0.20 (0.49)
C/G 2,629 0.68 (1.39) 1,267 0.89 (1.69) 1,362 0.49 (1.01) 0.21 (0.56) 0.30 (0.68) 0.14 (0.40) 0.24 (0.60) 0.31 (0.71) 0.18 (0.46) 0.22 (0.54) 0.29 (0.61) 0.16 (0.46)
G/G 9,139 0.71 (1.40) 4,615 0.88 (1.63) 4,524 0.53 (1.09) 0.22 (0.56) 0.29 (0.66) 0.15 (0.43) 0.25 (0.57) 0.29 (0.64) 0.20 (0.48) 0.23 (0.56) 0.29 (0.64) 0.18 (0.45)
P value 0.338 0.629 0.659 0.350 0.739 0.612 0.944 0.835 0.980 0.282 0.306 0.659
Effect size (CI 95%)c −0.028
(−0.086,
0.03)
−0.024
(−0.12,
0.072)
−0.013
(−0.073,
0.046)
−0.011
(−0.034,
0.012)
−0.007
(−0.045,
0.032)
−0.006
(−0.03,
0.017)
−0.001
(−0.024,
0.022)
0.004
(−0.034,
0.042)
<0.001
(−0.026,
0.026)
−0.013
(−0.036,
0.010)
−0.019
(−0.056,
0.018)
−0.006
(−0.032,
0.020)
SHANK3
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Table 1 Association between five SNPs and autistic-like traits (Continued)
rs9616915 0.49
(T)
C/C 3,116 0.74 (1.53) 1,589 0.96 (1.84) 1,527 0.52 (1.07) 0.23 (0.60) 0.32 (0.72) 0.14 (0.43) 0.27 (0.62) 0.33 (0.73) 0.20 (0.48) 0.24 (0.58) 0.31 (0.68) 0.18 (0.44)
C/T 5,839 0.68 (1.32) 2,906 0.83 (1.51) 2,933 0.53 (1.08) 0.22 (0.56) 0.29 (0.65) 0.16 (0.44) 0.24 (0.54) 0.28 (0.60) 0.20 (0.47) 0.22 (0.52) 0.26 (0.58) 0.18 (0.45)
T/T 2,927 0.68 (1.38) 1,461 0.88 (1.62) 1,466 0.49 (1.04) 0.21 (0.53) 0.29 (0.62) 0.14 (0.41) 0.24 (0.56) 0.28 (0.64) 0.19 (0.48) 0.24 (0.57) 0.31 (0.67) 0.16 (0.45)
P value 0.194 0.425 0.445 0.182 0.274 0.662 0.164 0.184 0.778 0.840 0.637 0.438
Effect size (CI 95%)c −0.026
(−0.064,
0.013)
−0.026
(−0.089,
0.038)
−0.015
(−0.055,
0.024)
−0.010
(−0.026,
0.005)
−0.014
(−0.04,
0.011)
−0.004
(−0.019,
0.012)
−0.011
(−0.027,
0.005)
−0.017
(−0.042,
0.008)
−0.003
(−0.02,
0.015)
−0.002
(−0.017,
0.014)
0.006
(−0.018,
0.030)
−0.007
(−0.024,
0.010)
aA-TAC mean values (SD).
bNominal significance, P value <0.05.
cEffect size presented as the regression coefficient (CI 95%).
A-TAC: Autism-Tics, ADHD, and Other Co-morbidities inventory.
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http://www.molecularautism.com/content/5/1/55analyses. To consider the possible influence of age at
testing, all analyses were also performed adjusted for age
(see Additional file 1). The Bonferroni corrected P value
was set to 0.0016 (<0.05/32, adjusted for eight A-TAC
measurements and four genetic regions).
We used the Quanto software to analyze which effect
sizes (β-value) we would be able to detect with a power
of 90% or more using an additive genetic model at a sig-
nificance level of 0.0016 [19]. The mean values and
standard deviation for ALTs, ALT modules, and NDPs
were used for the power analyses (N = 12,319). For ALTs
we had 90% power to detect the following effect sizes: β-
value between 0.08 and 0.09 for all SNPs except for
rs36269 (β = 0.12, MAF = 0.13). For the ALT domains
(language and social impairment, and restricted and re-
petitive behavior) the effect size (β-values) ranged be-
tween 0.04 and 0.05 and for the genetic factors for
NDPs it ranged between 0.03 and 0.06.
Results and discussion
Our approach was to investigate ALTs and common
genetic variations previously implicated in ASD, that is,
polymorphisms in CNTNAP2, SHANK3, RELN, and the
SNP rs4307059 between CDH9 and CDH10. We could
not find any significant association with ALTs for any of
the investigated SNPs, however, we did see a nominal
significance for the association between the CNTNAP2
SNP rs7794745 and both social interaction impairment
and total ALT scores (Table 1).
In the CNTNAP2 gene, the SNP rs7794745 has been
associated with autistic disorder [20] while the SNP
rs2710102 has mainly been associated with languageTable 2 ASDa case–control analyses
Gene SNP Genotype N
CDH 9/10 rs4307059 C/C 1
T/C 3
T/T 3
CNTNAP2 rs2710102 A/A 2
A/G 4
G/G 1
CNTNAP2 rs7794745 A/A 4
T/A 4
T/T 5
RELN rs362691 C/C + C/G 2
G/G 6
SHANK3 rs9616915 C/C 3
T/C 3
T/T 2
aAbove the score 8.5 on A-TAC.
bUncorrected P value.
ASD: Autism spectrum disorder; A-TAC: Autism-Tics, ADHD, and Other Co-morbiditieproblems [11]. A study by Whitehouse et al. found nom-
inal significance between rs2710102 (CNTNAP2) and
quantitative measures of early language acquisition in
the general population [10], which was not replicated in
our study (Table 1).
The SNP rs4307059 in the CDH 9/10 region has previ-
ously been associated with ASD in a GWAS [5], and was
replicated in a study by Ma et al. [21]. This SNP has also
been associated with social communication impairments
in a large population [9], however, in line with the re-
sults from the two GWAS for autistic traits [22,23], this
could not be replicated in our study (Table 1). However,
it should be noted that one of the ALT GWAS included
a pooled SNP analysis [23] and the other had a sample
size of 965 subjects [22]. The inconsistency in results
may also be due to the use of different measures of ALTs
in the studies. To compare our results from previous
case–control studies, we used the A-TAC score as a proxy
for an ASD diagnosis [17]; rs4307059 was not significantly
associated in this case–control analysis (Table 2). Notably,
we had low statistical power in these analyses due to the
small number of children with A-TAC scores correspond-
ing to an ASD diagnosis.
The rs362691 in RELN has been associated with ASD
in a recent meta-analysis that included five association
studies [24]; one of the included studies showed signifi-
cant association [25]. In SHANK3, mainly rare genetic
variations have been identified in subjects with ASD [14]
and association analysis for rs9616915 has previously
shown negative results for association with ASD in
both European and Han Chinese populations [26]. The
previous negative findings do not rule out a potential(case/control) P valueb OR (CI 95%)
2/1,651 0.835 1.087 (0.541-2.184)
7/5,527 1.160 (0.714-1.884)
6/4,730
5/3,223 0.800 0.806 (0.419-1.551)
4/5,932 0.846 (0.468-1.529)
7/2,735
1/4,963 0.125 0.351 (0.127-0.972)
0/5,493 0.422 (0.152-1.168)
/1,559
0/2,820 0.933 1.023 (0.601-1.742)
3/9,076
0/3,086 0.094 0.764 (0.425-1.373)
1/5,808 1.371 (0.769-2.447)
1/2,906
s inventory.
Table 3 Association between genetic factors for neurodevelopmental problems (NDPs) and five SNPs
General NDPa Impulsivitya Learning problemsa Tics and autisma
Gene/
SNP
MAF Genotype N All N Boys N Girls All Boys Girls All Boys Girls All Boys Girls
CDH9/10
rs4307059 0.37
(C)
C/C 1,149 0.128 (0.70) 538 0.235 (0.72) 611 0.034 (0.66) 0.032 (0.53) 0.034 (0.53) 0.030 (0.52) 0.002 (0.59) 0.017 (0.62) −0.010
(0.57)
0.067 (0.51) 0.144 (0.51) −0.002
(0.49)
T/C 3,923 0.172 (0.71) 1,998 0.275 (0.73) 1,925 0.064 (0.68) 0.028 (0.54) 0.021 (0.55) 0.034 (0.53) 0.051 (0.62) 0.085 (0.65) 0.016 (0.58) 0.069 (0.55) 0.138 (0.58) −0.003
(0.50)
T/T 3,424 0.132 (0.69) 1,711 0.244 (0.71) 1,713 0.019 (0.66) 0.023 (0.54) 0.038 (0.55) 0.009 (0.52) 0.031 (0.62) 0.066 (0.65) −0.004
(0.59)
0.057 (0.50) 0.105 (0.53) 0.009 (0.47)
P valueb 0.962 0.661 0.811 0.554 0.571 0.959 0.401 0.474 0.702 0.734 0.702 0.695
Effect size (CI 95%)c 0.001
(−0.021,
0.022)
0.007
(−0.024,
0.037)
−0.004
(−0.034,
0.027)
0.005
(−0.011,
0.021)
0.006
(−0.016,
0.029)
0.001
(−0.024,
0.025)
−0.007
(−0.023,
0.009)
−0.008
(−0.028,
0.013)
−0.005
(−0.033,
0.022)
0.002
(−0.012,
0.017)
0.004
(−0.017,
0.025)
0.004
(−0.018,
0.026)
CNTNAP2
rs2710102 0.48
(G)
A/A 2,316 0.121 (0.70) 1,153 0.203 (0.72) 1,163 0.040 (0.68) 0.004 (0.53) 0.002 (0.54) 0.007 (0.51) 0.050 (0.61) 0.056 (0.62) 0.043 (0.60) 0.057 (0.53) 0.126 (0.56) −0.012
(0.49)
A/G 4,242 0.158 (0.70) 2,126 0.274 (0.72) 2,116 0.041 (0.65) 0.030 (0.54) 0.037 (0.56) 0.023 (0.53) 0.033 (0.63) 0.075 (0.67) −0.010
(0.58)
0.069 (0.52) 0.125 (0.55) 0.013 (0.49)
G/G 1,924 0.164 (0.70) 966 0.268 (0.71) 958 0.059 (0.68) 0.040 (0.54) 0.036 (0.55) 0.043 (0.53) 0.027 (0.60) 0.063 (0.63) −0.008
(0.57)
0.066 (0.53) 0.130 (0.56) 0.001 (0.49)
P valueb 0.501 0.135 0.634 0.344 0.315 0.767 0.450 0.692 0.167 0.768 0.856 0.746
Effect size (CI 95%)c 0.007
(−0.014,
0.029)
0.025
(−0.008,
0.057)
−0.006
(−0.032,
0.019)
0.008
(−0.009,
0.025)
0.013
(−0.013,
0.039)
0.003
(−0.018,
0.025)
−0.007
(−0.025,
0.011)
0.006
(−0.024,
0.037)
−0.015
(−0.037,
0.006)
0.002
(−0.013,
0.018)
−0.002
(−0.027,
0.022)
0.002
(−0.008,
0.012)
rs7794745 0.36
(T)
A/A 3,499 0.144 (0.70) 1,714 0.251 (0.72) 1,785 0.041 (0.67) 0.023 (0.53) 0.028 (0.54) 0.019 (0.53) 0.022 (0.61) 0.048 (0.63) −0.004
(0.58)
0.075 (0.53) 0.140 (0.55) 0.013 (0.49)
T/A 3,947 0.156 (0.70) 2,010 0.269 (0.71) 1,937 0.039 (0.67) 0.028 (0.54) 0.035 (0.56) 0.021 (0.53) 0.046 (0.62) 0.082 (0.66) 0.009 (0.58) 0.058 (0.53) 0.116 (0.56) −0.001
(0.49)
T/T 1,110 0.146 (0.70) 556 0.225 (0.73) 554 0.068 (0.65) 0.031 (0.53) 0.020 (0.56) 0.042 (0.51) 0.042 (0.63) 0.067 (0.63) 0.017 (0.62) 0.050 (0.51) 0.111 (0.53) −0.012
(0.48)
P valueb 0.583 0.169 0.583 0.590 0.563 0.905 0.811 0.547 0.296 0.112 0.210 0.567
Effect size (CI 95%)c −0.006
(−0.028,
0.016)
−0.023
(−0.055,
0.010)
0.007
(−0.019,
0.034)
0.005
(−0.012,
0.021)
0.007
(−0.017,
0.031)
0.001
(−0.021,
0.023)
0.002
(−0.014,
0.018)
−0.008
(−0.032,
0.017)
0.012
(−0.01,
0.034)
−0.012
(−0.026,
0.003)
−0.015
(−0.038,
0.008)
−0.003
(−0.013,
0.007)
RELN
rs362691 0.13
(C)
C/C 156 0.097 (0.68) 80 0.149 (0.69) 76 0.043 (0.66) −0.065
(0.52)
−0.111
(0.45)
−0.017
(0.58)
0.097 (0.68) 0.094 (0.56) 0.100 (0.78) 0.087 (0.51) 0.194 (0.53) −0.025
(0.46)
C/G 1,823 0.126 (0.69) 874 0.270 (0.69) 949 −0.007
(0.65)
0.019 (0.55) 0.055 (0.57) −0.015
(0.53)
0.025 (0.63) 0.055 (0.66) −0.002
(0.60)
0.063 (0.54) 0.114 (0.58) 0.016 (0.49)
G/G 6,483 0.156 (0.70) 3,270 0.253 (0.72) 3,213 0.058 (0.67) 0.029 (0.53) 0.023 (0.55) 0.036 (0.52) 0.039 (0.61) 0.071 (0.65) 0.006 (0.57) 0.063 (0.52) 0.128 (0.55) −0.002
(0.49)
P valueb 0.545 0.879 0.288 0.444 0.856 0.115 0.957 0.802 0.521 0.632 0.715 0.646
Jonsson
et
al.M
olecular
A
utism
2014,5:55
Page
6
of
9
http://w
w
w
.m
olecularautism
.com
/content/5/1/55
Table 3 Association between genetic factors for neurodevelopmental problems (NDPs) and five SNPs (Continued)
Effect size (95% CI)c −0.010
(−0.041,
0.022)
0.003
(−0.04,
0.047)
−0.026
(−0.073,
0.022)
−0.009
(−0.033,
0.014)
0.003
(−0.029,
0.035)
−0.030
(−0.067,
0.007)
0.001
(−0.023,
0.024)
−0.004
(−0.033,
0.026)
0.014
(−0.029,
0.056)
0.005
(−0.016,
0.026)
0.006
(−0.025,
0.036)
0.008
(−0.026,
0.042)
SHANK3
rs9616915 0.49
(T)
C/C 2,170 0.149 (0.71) 1,123 0.263 (0.73) 1,047 0.028 (0.65) 0.039 (0.54) 0.041 (0.56) 0.037 (0.52) 0.020 (0.60) 0.039 (0.62) 0.001 (0.58) 0.060 (0.54) 0.140 (0.55) −0.025
(0.51)
C/T 4,182 0.161 (0.70) 2,044 0.266 (0.72) 2,138 0.060 (0.66) 0.037 (0.54) 0.053 (0.55) 0.022 (0.53) 0.039 (0.61) 0.075 (0.64) 0.004 (0.58) 0.057 (0.52) 0.096 (0.54) 0.020 (0.49)
T/T 2,061 0.120 (0.69) 1,048 0.232 (0.70) 1,013 0.005 (0.66) −0.010
(0.52)
−0.030
(0.54)
0.011 (0.50) 0.042 (0.63) 0.083 (0.68) −0.001
(0.57)
0.081 (0.53) 0.169 (0.58) −0.009
(0.46)
P valueb 0.703 0.870 0.716 0.152 0.068 1.00 0.377 0.308 0.994 0.273 0.266 0.659
Effect size (CI 95%)c 0.004
(−0.017,
0.025)
0.002
(−0.027,
.032)
0.006
(−0.025,
0.037)
−0.012
(−0.028,
0.004)
−0.020
(−0.042,
0.001)
0.001
(−0.025,
0.025)
0.007
(−0.009,
0.023)
0.011
(−0.01,
0.031)
0.001
(−0.028,
0.028)
0.008
(−0.006,
0.022)
0.012
(−0.009,
0.032)
0.005
(−0.017,
0.028)
aMean values (SD).
bUncorrected P value.
cEffect size presented as the regression coefficient (95% CI).
A-TAC: Autism-Tics, ADHD, and Other Co-morbidities inventory.
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http://www.molecularautism.com/content/5/1/55influence of common variation in SHANK3 or RELN on
autistic-like traits, which has not been investigated previ-
ously. However, in our study we did not find significant
associations between ALTs and rs9616915 or rs362691
(Table 1).
Since there is a large co-morbidity between NDPs, we
also explored the influence of our ASD candidate SNPs
on four genetic NDP factors designed to have 100% her-
itability [18], that is, we explored the genetic etiology of
the co-morbidity among NDPs. These analyses did not
show a major influence of these SNPs on the genetic
NDP factors (Table 3).
In line with the GWAS published for autistic traits
[22,23], we did not find significant association between
the investigated SNPs and ALTs in our large population,
although nominal significance is observed for the
CNTNAP2 SNP rs7794745. Hence, our results suggest
that these genes, which previously have been found
associated with ASD diagnosis, do not have any major
influence on ALTs in children from the general popu-
lation. However, it cannot be excluded that other vari-
ants in the same genes may have an effect since our
selected SNPs do not capture all variations within our
selected genes. Further studies that investigate the in-
fluence of genetic variation on different measures of
ALTs are highly warranted to better understand the
genetics of autism related phenotypes and neurodeve-
lopmental disorders.
Conclusion
Taken together, our association analyses between the in-
vestigated autism candidate regions and ALTs do not
suggest a major influence on ALTs in children from the
general population.
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